Fumarylacetoacetate hydrolase deficient pigs are a novel large animal model of metabolic liver disease
about
Curative ex vivo liver-directed gene therapy in a pig model of hereditary tyrosinemia type 1.Potential and Challenges of Induced Pluripotent Stem Cells in Liver Diseases Treatment.New Tools in Experimental Cellular Therapy for the Treatment of Liver Diseases.Efficient liver repopulation of transplanted hepatocyte prevents cirrhosis in a rat model of hereditary tyrosinemia type IFumarylacetoacetate Hydrolase Knock-out Rabbit Model for Hereditary Tyrosinemia Type 1.Genetically engineered livestock for biomedical models.Concise Review: Liver Regenerative Medicine: From Hepatocyte Transplantation to Bioartificial Livers and Bioengineered Grafts.Genome editing revolutionize the creation of genetically modified pigs for modeling human diseases.Noninvasive 3-dimensional imaging of liver regeneration in a mouse model of hereditary tyrosinemia type 1 using the sodium iodide symporter gene.In Vitro Generated Hepatocyte-Like Cells: A Novel Tool in Regenerative Medicine and Drug Discovery.Fah Knockout Animals as Models for Therapeutic Liver Repopulation.Novel technology for liver regeneration and replacement.Chronic Phenotype Characterization of a Large-Animal Model of Hereditary Tyrosinemia Type 1.Dynamic microRNAome profiles in the developing porcine liver.Stem Cell Therapies for Treatment of Liver Disease.The Liver in Tyrosinemia Type I: Clinical Management and Course in Quebec.A Pre-Clinical Large Animal Model of Sustained Liver Injury and Regeneration Stimulus
P2860
Q30856034-FACDB178-E318-4FB1-94F4-5E6204930826Q35667098-19AF03CC-838D-40A0-9D64-7966684F272BQ35990789-B889E639-8100-46C7-A4A2-96C5732CD744Q37166557-1AF870A6-6757-47DE-A6FD-9A94D7201DAEQ37735158-73029790-2FED-47EF-BD06-D02EAF80EFF0Q38714822-A02C709E-3750-4AE5-8C07-DEE8C61C7F4EQ38820033-5055FF3D-A3AE-481D-8CD4-70B935B9CF90Q38901709-9195227D-0C76-488F-8CF9-BB1FE5D63F2EQ39080593-A3D59E22-A5AA-4421-B521-188A7E7E54C8Q39410484-F1096609-8A5C-4AD2-B906-57044313D3A8Q40114866-F1F1363C-A93F-40B4-BACB-B7E754022C28Q43031297-B9DD81C8-F5AD-495F-B510-C179E4E77DA1Q47134192-C08E5DD5-5AB2-498D-890F-A4897583100DQ50485266-F4236F75-1CE7-4854-9773-46673B2C06B6Q51032622-82BDA7DF-DC7D-491C-A414-416A9D00EDB9Q51817716-E741A0BF-6AC3-4BC4-9612-AD7284663BFDQ57292505-9C71B369-BEAA-475E-8837-B92BA200BCDE
P2860
Fumarylacetoacetate hydrolase deficient pigs are a novel large animal model of metabolic liver disease
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Fumarylacetoacetate hydrolase ...... del of metabolic liver disease
@ast
Fumarylacetoacetate hydrolase ...... del of metabolic liver disease
@en
type
label
Fumarylacetoacetate hydrolase ...... del of metabolic liver disease
@ast
Fumarylacetoacetate hydrolase ...... del of metabolic liver disease
@en
prefLabel
Fumarylacetoacetate hydrolase ...... del of metabolic liver disease
@ast
Fumarylacetoacetate hydrolase ...... del of metabolic liver disease
@en
P2093
P2860
P1433
P1476
Fumarylacetoacetate hydrolase ...... del of metabolic liver disease
@en
P2093
Bruce Amiot
Cary O Harding
Jaime Glorioso
James E Fisher
Joseph B Lillegard
Milton J Finegold
Piero Rinaldo
Raymond D Hickey
Ronald Marler
Scott L Nyberg
P2860
P304
P356
10.1016/J.SCR.2014.05.003
P577
2014-05-14T00:00:00Z